Vendor, Bilthoven, NLD
Intravacc B.V.
UEI RY3NEWMNZA63, CAGE H2MN6
1 award and -$964,757 obligated between August 20, 2026 and August 20, 2026, 100% under full and open competition, against 1.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)NAICS 541715 | -$964,757 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 1 |
| Definitive Contract | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75N93020C00037Definitive Contract, August 20, 2026, Full and Open Competition, 1 offers | National Institutes of Health NiaidNational Institutes of Health | To Develop an Intramuscular Inactivated Whole Virus Vaccine from Early Product Selection Through a Phase I Clinical Trial to Induce ProtectiNAICS 541715, PSC AJ12 | -$964,757 |
- Product and service codes
- AJ12 General Science And Technology R&D Services; General Science And Technology; Applied Research
- Transactions
- 1 across 1 awards